CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Gujarat Terce Laboratories Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Gujarat Terce Laboratories Ltd
D/ 801 & 802 Vastrapur, High Street
Phone: +91 7966633701p:+91 7966633701 AHMEDABAD, 380015  India Ticker: 524314524314
Business Summary
Gujarat Terce Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of medicines and healthcare products. Its product basket includes branded as well as generic formulations offering solutions for disease prevention and control. It offers a range of products under 52 brands, totaling 135 items approximately, and its portfolio covers 10 therapeutic categories such as respiratory, gynecology, antibiotics, pain therapy, gastrology, nutraceutical, and ayurvedic therapies. The Company’s brands include Acolate, Codimol, Terflora Z, Thyter, Tynol, Moxxil and Vitfol, among others. It caters to both domestic and international markets. The manufacturing facility of the Company is located at Chhatral in Gandhinagar, Gujarat.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board Natwarbhai P.Prajapati 67 1/1/2023
Chief Executive Officer, Managing Director, Whole-Time Director AalapPrajapati 34 10/28/2021 3/31/2018
Chief Financial Officer Bhagirath R.Maurya 46 12/17/2018 12/17/2018
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 286 (As of 3/31/2024)
Outstanding Shares: 7,420,300 (As of 9/30/2024)
Stock Exchange: BOM
Fax Number: +91 7966633713


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 28, 2025